Editorial Opinion JAMA Cardiology—The Year in Review, 2017 Robert O. Bonow, MD, MS After the run up to the launch of JAMA Cardiology in April 2016 Table. JAMA Cardiology Statistics for 2017 and the 9 issues that followed in its first year, 2017 marked our a first full year of publishing. Looking back, 2017 was a period Characteristic Result of steady growth in original science manuscripts, opinions, re- Manuscript Data views, and educational con- Major manuscripts received, No. 1328 tent and continued interest in Research manuscripts received, No. 1040 Related article the journal by the cardiovas- Acceptance rate, % cular community. The 1328 Overall 17 manuscript submissions (Table) represent an increase of 10.8% Research 9 and the 1040 research submissions represent an increase of Peer reviewer turnaround, median, d 13 10% compared with the comparable 12 months of submis- Time from receipt to first decision without peer review, median, d 14 sions in 2016. As with other competitive journals in our spe- Time from acceptance to publication, median, d 54 cialty, our acceptance rate of original science manuscripts has Time from receipt to publication, median, d 122 fallen into single digits. Information Dissemination Data Our weekly online content is now sent to nearly 25 000 Recipients of electronic table of contents per week, No. 24 723 readers, and there were more than 900 000 full-text/PDF Full-text/PDF downloads per year, No. 902 537 downloads last year. We maintain an active presence on so- Twitter followers, No. 9536 cial media, and remarkably, our Twitter and Facebook follow- Facebook followers, No. 46 830 ers have increased by 76% and 45%, respectively, during the Top 3 articles, Altmetric scoreb past year. Feedback on our monthly podcasts has been very Brandt et al,1 Hospital Admissions for Myocardial Infarction and 1221 positive. As a member of the JAMA Network, our close con- Stroke Before and After the Trans-Fatty Acid Restrictions in nections with the dedicated JAMA editors and staff facilitate New York 2 the many channels of delivery of our weekly and monthly con- Wang et al, Accuracy of Wrist-Worn Heart Rate Monitors 1209 3 tent. Cardiovascular science continues to advance at a breath- Scragg et al, Effect of Monthly High-Dose Vitamin D 992 Supplementation on Cardiovascular Disease in the Vitamin D taking pace, as does its opportunities for multimedia dissemi- Assessment Study: A Randomized Clinical Trial nation, and it is a privilege to serve as a conduit of fresh ideas, Top 3 most cited articles, No. of citations, 2016-2017 new scientific findings, and informative reviews. Edwards et al,4 Development and Validation of a Risk Prediction 41 Model for In-Hospital Mortality After Transcatheter Aortic The Table also lists the articles that have received the Valve Replacement highest Altmetric scores in 2017 and the most citations over Hsu et al,5 Oral Anticoagulant Therapy Prescription in Patients 41 the past 2 years. This brief listing provides a glimpse of the With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights from the NCDR PINNACLE Registry broad cardiovascular landscape that is covered in JAMA Car- McGuire et al,6 Association Between Sitagliptin Use and Heart 36 diology. Two articles highlight the ongoing interest among Failure Hospitalization and Related Outcomes in Type 2 professional and lay readers on topics related to nutrition. Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Brandt et al1 identified an association between counties in a Data are based on major manuscripts, defined as all research, review, New York that implemented bans in trans-fats and hospital educational, and opinion articles (does not include letters). admissions for myocardial infarction and stroke compared b Altmetric score is a measure of electronic news and social media attention. with counties with trans-fat bans, and Scragg et al3 in New Zealand reported a clinical trial in which vitamin D supple- ments did not have a positive association on incident cardio- authors and readers. As a work in progress, this feedback has vascular disease. The article by Wang et al2 on the accuracy helped to fine-tune the look and feel of the journal. Our con- of wrist-worn heart monitors points to the growing aware- tent has been listed in PubMed since July 2016. In 2017, ness of the possibilities of digital health. Our highest-cited JAMA Cardiology was accepted into Web of Science, and we articles cover topics of valvular heart disease and atrial fibril- anticipate the journal’s first impact factor will be released in lation from important national registries4,5 and an analysis June of this year. of the lack of association of dipeptidyl peptidase 4 inhibitors The editors must also thank the hundreds of our col- and incident heart failure in patients with diabetes enrolled leagues who have served as peer reviewers.7 We recognize the in international clinical trials.6 time and effort required for effective peer review, and we are The primary value of the journal rests on its standing as grateful for the knowledge and insights our reviewers have vol- a home for exceptional authors, and on behalf of the editors, unteered to enhance the analytic methods, data interpreta- I sincerely thank our authors who have accepted JAMA Car- tion, and take-home messages of our manuscripts. This ef- diology as the source for publishing some of their finest fort is not rewarded appropriately, but it remains the backbone efforts. We greatly appreciate the constructive comments, of manuscript evaluation and is greatly appreciated. Percep- suggestions, and criticisms we continue to receive from our tive reviews often translate into editorials and invited com- jamacardiology.com (Reprinted) JAMA Cardiology May 2018 Volume 3, Number 5 373 © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 Opinion Editorial mentaries that accompany the original article and help to place as we strive to select the most seminal, interesting, and the new findings in context. thought-provoking articles and opinions of interest to our read- Scientific publishing is a team sport, and maintaining this ership. level of productivity requires the dedicated efforts of JAMA As JAMA Cardiology matures, we look forward to main- Cardiology’s talented deputy and associate editors who take taining the momentum we have created in our first 2 years of valuable time from their busy professional and personal lives publishing and achieving our vision to take a position among to oversee the flow of manuscripts and collectively provide the the premier journals in our discipline. Through your contri- strategic vision of the journal. Our group spends hundreds of butions to our scientific manuscripts, reviews, Viewpoints, Edi- hours critiquing manuscripts, communicating with authors and torials, and Invited Commentaries, we will continue to con- reviewers, and making editorial decisions to generate the con- tribute prominently to the discourse that is fueling the tent of our pages. Working together, we deliberate each week advances in cardiovascular medicine. ARTICLE INFORMATION and stroke before and after the trans-fatty acid 5. Hsu JC, Maddox TM, Kennedy KF, et al. Oral Author Affiliations: Department of Medicine, restrictions in New York. JAMA Cardiol. 2017;2(6): anticoagulant therapy prescription in patients with Northwestern University Feinberg School of 627-634. doi:10.1001/jamacardio.2017.0491 atrial fibrillation across the spectrum of stroke risk: Medicine, Chicago, Illinois; Editor, JAMA Cardiology. 2. Wang R, Blackburn G, Desai M, et al. Accuracy of insights from the NCDR PINNACLE Registry. JAMA wrist-worn heart rate monitors. JAMA Cardiol.2017; Cardiol. 2016;1(1):55-62. doi:10.1001/jamacardio Corresponding Author: Robert O. Bonow, MD, MS, .2015.0374 Department of Medicine, Northwestern University 2(1):104-106. doi:10.1001/jamacardio.2016.3340 Feinberg School of Medicine, 251 E Huron St, Galter 3. Scragg R, Stewart AW, Waayer D, et al. Effect of 6. McGuire DK, Van de Werf F, Armstrong PW, et al; 3-150, Chicago, IL 60611 ([email protected]). monthly high-dose vitamin D supplementation on Trial Evaluating Cardiovascular Outcomes With cardiovascular disease in the Vitamin D Assessment Sitagliptin (TECOS) Study Group. Association Published Online: March 21, 2018. between sitagliptin use and heart failure doi:10.1001/jamacardio.2017.4979 Study: a randomized clinical trial. JAMA Cardiol. 2017;2(6):608-616. doi:10.1001/jamacardio.2017.0175 hospitalization and related outcomes in type 2 Conflict of Interest Disclosures: The author has diabetes mellitus: secondary analysis of a completed and submitted the ICMJE Form for 4. Edwards FH, Cohen DJ, O’Brien SM, et al; randomized clinical trial. JAMA Cardiol. 2016;1(2): Disclosure of Potential Conflicts of Interest and Steering Committee of the Society of Thoracic 126-135. doi:10.1001/jamacardio.2016.0103 none were reported. Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 7. JAMA Cardiology peer reviewers in 2017 Development and validation of a risk prediction [published online March 21, 2018]. JAMA Cardiol. REFERENCES model for in-hospital mortality after transcatheter doi:10.1001/jamacardio.2017.4980 1. Brandt EJ, Myerson R, Perraillon MC, Polonsky aortic valve replacement. JAMA Cardiol. 2016;1(1): TS. Hospital admissions for myocardial infarction 46-52. doi:10.1001/jamacardio.2015.0326 374 JAMA Cardiology May 2018 Volume 3, Number 5 (Reprinted) jamacardiology.com © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021.